167 related articles for article (PubMed ID: 31213479)
1. Extracting Pathway-level Signatures from Proteogenomic Data in Breast Cancer Using Independent Component Analysis.
Liu W; Payne SH; Ma S; Fenyö D
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S169-S182. PubMed ID: 31213479
[TBL] [Abstract][Full Text] [Related]
2. Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors.
Ma W; Chen LS; Özbek U; Han SW; Lin C; Paulovich AG; Zhong H; Wang P
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S66-S81. PubMed ID: 31281117
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance.
De Marchi T; Pyl PT; Sjöström M; Klasson S; Sartor H; Tran L; Pekar G; Malmström J; Malmström L; Niméus E
J Proteome Res; 2021 May; 20(5):2983-3001. PubMed ID: 33855848
[TBL] [Abstract][Full Text] [Related]
4. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.
Zhang Y; Chen F; Chandrashekar DS; Varambally S; Creighton CJ
Nat Commun; 2022 May; 13(1):2669. PubMed ID: 35562349
[TBL] [Abstract][Full Text] [Related]
5. Proteome-wide onco-proteogenomic somatic variant identification in ER-positive breast cancer.
Dimitrakopoulos L; Prassas I; Sieuwerts AM; Diamandis EP; Martens JWM; Charames GS
Clin Biochem; 2019 Apr; 66():63-75. PubMed ID: 30684468
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research.
Hughes CS; McConechy MK; Cochrane DR; Nazeran T; Karnezis AN; Huntsman DG; Morin GB
Sci Rep; 2016 Oct; 6():34949. PubMed ID: 27713570
[TBL] [Abstract][Full Text] [Related]
7. The perennial fruit tree proteogenomics atlas: a spatial map of the sweet cherry proteome and transcriptome.
Xanthopoulou A; Moysiadis T; Bazakos C; Karagiannis E; Karamichali I; Stamatakis G; Samiotaki M; Manioudaki M; Michailidis M; Madesis P; Ganopoulos I; Molassiotis A; Tanou G
Plant J; 2022 Mar; 109(5):1319-1336. PubMed ID: 34842310
[TBL] [Abstract][Full Text] [Related]
8. Computational identification of micro-structural variations and their proteogenomic consequences in cancer.
Lin YY; Gawronski A; Hach F; Li S; Numanagic I; Sarrafi I; Mishra S; McPherson A; Collins CC; Radovich M; Tang H; Sahinalp SC
Bioinformatics; 2018 May; 34(10):1672-1681. PubMed ID: 29267878
[TBL] [Abstract][Full Text] [Related]
9. Challenges in proteogenomics: a comparison of analysis methods with the case study of the DREAM proteogenomics sub-challenge.
Eicher T; Patt A; Kautto E; Machiraju R; Mathé E; Zhang Y
BMC Bioinformatics; 2019 Dec; 20(Suppl 24):669. PubMed ID: 31861998
[TBL] [Abstract][Full Text] [Related]
10. Survey and comparative assessments of computational multi-omics integrative methods with multiple regulatory networks identifying distinct tumor compositions across pan-cancer data sets.
Wei Z; Zhang Y; Weng W; Chen J; Cai H
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32533167
[TBL] [Abstract][Full Text] [Related]
11. Credentialing Individual Samples for Proteogenomic Analysis.
Zhao W; Li J; Akbani R; Liang H; Mills GB
Mol Cell Proteomics; 2018 Aug; 17(8):1515-1530. PubMed ID: 29716986
[TBL] [Abstract][Full Text] [Related]
12. Proteogenomic data and resources for pan-cancer analysis.
Li Y; Dou Y; Da Veiga Leprevost F; Geffen Y; Calinawan AP; Aguet F; Akiyama Y; Anand S; Birger C; Cao S; Chaudhary R; Chilappagari P; Cieslik M; Colaprico A; Zhou DC; Day C; Domagalski MJ; Esai Selvan M; Fenyö D; Foltz SM; Francis A; Gonzalez-Robles T; Gümüş ZH; Heiman D; Holck M; Hong R; Hu Y; Jaehnig EJ; Ji J; Jiang W; Katsnelson L; Ketchum KA; Klein RJ; Lei JT; Liang WW; Liao Y; Lindgren CM; Ma W; Ma L; MacCoss MJ; Martins Rodrigues F; McKerrow W; Nguyen N; Oldroyd R; Pilozzi A; Pugliese P; Reva B; Rudnick P; Ruggles KV; Rykunov D; Savage SR; Schnaubelt M; Schraink T; Shi Z; Singhal D; Song X; Storrs E; Terekhanova NV; Thangudu RR; Thiagarajan M; Wang LB; Wang JM; Wang Y; Wen B; Wu Y; Wyczalkowski MA; Xin Y; Yao L; Yi X; Zhang H; Zhang Q; Zuhl M; Getz G; Ding L; Nesvizhskii AI; Wang P; Robles AI; Zhang B; Payne SH;
Cancer Cell; 2023 Aug; 41(8):1397-1406. PubMed ID: 37582339
[TBL] [Abstract][Full Text] [Related]
13. A prognostic prediction model for ovarian cancer using a cross-modal view correlation discovery network.
Wang H; Han X; Ren J; Cheng H; Li H; Li Y; Li X
Math Biosci Eng; 2024 Jan; 21(1):736-764. PubMed ID: 38303441
[TBL] [Abstract][Full Text] [Related]
14. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
[TBL] [Abstract][Full Text] [Related]
15. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.
Huang KL; Li S; Mertins P; Cao S; Gunawardena HP; Ruggles KV; Mani DR; Clauser KR; Tanioka M; Usary J; Kavuri SM; Xie L; Yoon C; Qiao JW; Wrobel J; Wyczalkowski MA; Erdmann-Gilmore P; Snider JE; Hoog J; Singh P; Niu B; Guo Z; Sun SQ; Sanati S; Kawaler E; Wang X; Scott A; Ye K; McLellan MD; Wendl MC; Malovannaya A; Held JM; Gillette MA; Fenyö D; Kinsinger CR; Mesri M; Rodriguez H; Davies SR; Perou CM; Ma C; Reid Townsend R; Chen X; Carr SA; Ellis MJ; Ding L
Nat Commun; 2017 Mar; 8():14864. PubMed ID: 28348404
[TBL] [Abstract][Full Text] [Related]
16. An overview of technologies for MS-based proteomics-centric multi-omics.
Rajczewski AT; Jagtap PD; Griffin TJ
Expert Rev Proteomics; 2022 Mar; 19(3):165-181. PubMed ID: 35466851
[TBL] [Abstract][Full Text] [Related]
17. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
18. Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.
Wu P; Heins ZJ; Muller JT; Katsnelson L; de Bruijn I; Abeshouse AA; Schultz N; Fenyö D; Gao J
Mol Cell Proteomics; 2019 Sep; 18(9):1893-1898. PubMed ID: 31308250
[TBL] [Abstract][Full Text] [Related]
19. Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer.
Zhan X; Cheng J; Huang Z; Han Z; Helm B; Liu X; Zhang J; Wang TF; Ni D; Huang K
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S37-S51. PubMed ID: 31285282
[TBL] [Abstract][Full Text] [Related]
20. Proteogenomic interrogation of cancer cell lines: an overview of the field.
Tsang O; Wong JWH
Expert Rev Proteomics; 2021 Mar; 18(3):221-232. PubMed ID: 33877947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
